Global Markets Direct Research

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.
Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.
Global Markets Direct Research
 

List of reports from Global Markets Direct Research

1  2    4    6  7  8  9  10  
Imaxio SA - Product Pipeline Review - 2015
3/31/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Imaxio SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Gastric Cancer - Pipeline Review, H1 2015
3/31/2015 | published by: Global Markets Direct
... therapeutic development for Gastric Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
HIV-1 Infection - Pipeline Review, H1 2015
3/31/2015 | published by: Global Markets Direct
... therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Myocardial Infarction - Pipeline Review, H1 2015
3/31/2015 | published by: Global Markets Direct
... therapeutic development for Myocardial Infarction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ischemic Stroke - Pipeline Review, H1 2015
3/31/2015 | published by: Global Markets Direct
... therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Liver Failure - Pipeline Review, H1 2015
3/26/2015 | published by: Global Markets Direct
... therapeutic development for Liver Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NGM Biopharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
American Gene Technologies International Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... International Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of American Gene Technologies International Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug ...  |  read more...
USD 1,500
Advenchen Laboratories, LLC - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Advenchen Laboratories, LLC’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Advanced Cancer Therapeutics - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Advanced Cancer Therapeutics’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Amplyx Pharmaceuticals, Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Amplyx Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Alethia Biotherapeutics Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Alethia Biotherapeutics Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Axxam SpA - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Axxam SpA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Abera Bioscience AB - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Abera Bioscience AB’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Sotio a.s. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Sotio a.s.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Abiogen Pharma S.p.A. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Abiogen Pharma S.p.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Amarna Therapeutics B.V. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Amarna Therapeutics B.V.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Afferent Pharmaceuticals, Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Afferent Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Agile Therapeutics, Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Agile Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Affimed Therapeutics AG - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Affimed Therapeutics AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Allergan, Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Allergan, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Ambrx, Inc. - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Ambrx, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Altor BioScience Corporation - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Altor BioScience Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Aeglea BioTherapeutics Holdings, LLC - Product Pipeline Review - 2015
3/26/2015 | published by: Global Markets Direct
... pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aeglea BioTherapeutics Holdings, LLC ’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism ...  |  read more...
USD 1,500
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015
3/26/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!